These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29348460)

  • 1. FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.
    Lee GH; Yoo KC; An Y; Lee HJ; Lee M; Uddin N; Kim MJ; Kim IG; Suh Y; Lee SJ
    Oncogene; 2018 Apr; 37(14):1857-1868. PubMed ID: 29348460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
    Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
    Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
    Chougule RA; Kazi JU; Rönnstrand L
    Oncotarget; 2016 Mar; 7(9):9964-74. PubMed ID: 26848862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of KRAS promotes the mesenchymal features of basal-type breast cancer.
    Kim RK; Suh Y; Yoo KC; Cui YH; Kim H; Kim MJ; Gyu Kim I; Lee SJ
    Exp Mol Med; 2015 Jan; 47(1):e137. PubMed ID: 25633745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
    Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
    Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
    Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer.
    Kim RK; Kaushik N; Suh Y; Yoo KC; Cui YH; Kim MJ; Lee HJ; Kim IG; Lee SJ
    Oncotarget; 2016 Aug; 7(33):53430-53442. PubMed ID: 27462787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
    Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
    Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
    Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion.
    Fenton SE; Hutchens KA; Denning MF
    Mol Carcinog; 2015 Oct; 54(10):1181-93. PubMed ID: 24976598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1.
    Lee JH; Jung SM; Yang KM; Bae E; Ahn SG; Park JS; Seo D; Kim M; Ha J; Lee J; Kim JH; Kim JH; Ooshima A; Park J; Shin D; Lee YS; Lee S; van Loo G; Jeong J; Kim SJ; Park SH
    Nat Cell Biol; 2017 Oct; 19(10):1260-1273. PubMed ID: 28892081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. αvβ6-Fyn Kinase Promotes Epithelial Phenotype in SYF Cells.
    Lee C; Ramos DM
    Anticancer Res; 2018 Jan; 38(1):165-168. PubMed ID: 29277769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
    J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer.
    Britschgi A; Andraos R; Brinkhaus H; Klebba I; Romanet V; Müller U; Murakami M; Radimerski T; Bentires-Alj M
    Cancer Cell; 2012 Dec; 22(6):796-811. PubMed ID: 23238015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
    Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
    Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.